News

According to a new study, a class of proteins that regulates cell repair and enhances cell growth-signaling systems could be a promising new target for the treatment of Alzheimer's and other neurodegenerative diseases.

Scientists from the University of Cambridge have identified a gene that can cause obesity, behavioral issues and postnatal depression when missing or impaired. The study, published in Cell, points to oxytocin as a potential treatment.

A treatment to move blood from the umbilical cord into the body of newborns who are limp, pale and with minimal breathing, known as non-vigorous, does not appear to increase the risk of neurodevelopmental impairment.

A pair of recent studies have uncovered previously unknown cellular mechanisms involved in neuronal protein aggregation and misfolding, key characteristics of Parkinson’s disease.

Cold Spring Harbor Laboratory Assistant Professor Gabrielle Pouchelon studies how the brain is wired early in life. In doing so, she hopes to find the origins of various brain dysfunctions and new ways to treat them.

A new model developed by researchers could help inform guidelines and improve evidence-based advice on the risks and benefits of fish consumption, especially during pregnancy.

Researchers from the Icahn School of Medicine at Mount Sinai have shed valuable light on the nuanced functions and intricate regulatory methods of RNA editing, a critical mechanism underlying brain development and disease.

Researchers have uncovered the role of the serotonin 2C receptor in regulating memory, providing new insights into the factors involved in healthy memory.

A study from Michigan Medicine's Kresge Hearing Research Institute was able to produce supranormal hearing in mice, while also supporting a hypothesis on the cause of hidden hearing loss in humans.

Researchers from Japan have successfully developed a chemical radiotracer that binds to α-synuclein fibrils, harmful protein aggregates typically seen in PD and DLB pathologies.